Lockdown policies brought on by the COVID-19 pandemic pose a threat to well-being. This study examined the effectiveness of three positive psychology interventions, with different time-orientations, on well-being as well as predictors of well-being during lockdown. Participants (n= 216) completed measures of lockdown characteristics, attachment orientation, and emotion regulation, were then randomly allocated to one… Continue reading Evaluating the impact of a time orientation intervention on #well-being during the #COVID-19 lockdown: past, present or future?
Category: Infectivology
Impact of Inappropriate #Antibiotic Therapy in Vancomycin-Resistant #Enterococcus Bacteremia
Vancomycin-resistant Enterococcus (VRE) bacteremia has significant morbidity and mortality. Empiric antibiotic regimens for treating patients with risk factors for multidrug-resistant organisms may not have medications directed at treating VRE.. ..The inpatient, 30-day, and 1-year mortality rates from VRE bacteremia were 23%, 31%, and 59%, respectively. Only 19% patients were discharged home. Inappropriate antibiotics were prescribed… Continue reading Impact of Inappropriate #Antibiotic Therapy in Vancomycin-Resistant #Enterococcus Bacteremia
Early High-Titer #Plasma Therapy to Prevent Severe #Covid-19 in Older Adults
Therapies to interrupt the progression of early coronavirus disease 2019 (Covid-19) remain elusive. Among them, convalescent plasma administered to hospitalized patients has been unsuccessful, perhaps because antibodies should be administered earlier in the course of illness. We conducted a randomized, double-blind, placebo-controlled trial of convalescent plasma with high IgG titers against severe acute respiratory syndrome… Continue reading Early High-Titer #Plasma Therapy to Prevent Severe #Covid-19 in Older Adults
Low vitamin #D status is associated with #coronavirus disease 2019 outcomes: A systematic review and meta-analysis
Observational studies suggest that the risk and clinical prognosis of coronavirus disease 2019 (COVID-19) are related to low vitamin D status; however, the data are inconsistent.. ..A total of 10 articles with 361, 934 participants were selected for meta-analysis. Overall, the pooled OR in the fixed-effect model showed that vitamin D deficiency or insufficiency was… Continue reading Low vitamin #D status is associated with #coronavirus disease 2019 outcomes: A systematic review and meta-analysis
mRNA #Covid-19 #vaccines
The Advisory Committee on Immunization Practices (ACIP) has issued interim recommendations for the use of Pfizer-BioNTech and Moderna COVID-19 vaccines for the prevention of coronavirus disease 2019 (COVID-19) in the United States. Both vaccines are lipid nanoparticle-formulated, nucleoside-modified mRNA vaccines encoding the prefusion spike glycoprotein of SARS-CoV-2, the virus that causes COVID-19. These interim CDC… Continue reading mRNA #Covid-19 #vaccines
#Baricitinib plus #Remdesivir for Hospitalized Adults with #Covid-19
Severe coronavirus disease 2019 (Covid-19) is associated with dysregulated inflammation. The effects of combination treatment with baricitinib, a Janus kinase inhibitor, plus remdesivir are not known. METHODS We conducted a double-blind, randomized, placebo-controlled trial evaluating baricitinib plus remdesivir in hospitalized adults with Covid-19. All the patients received remdesivir (≤10 days) and either baricitinib (≤14 days)… Continue reading #Baricitinib plus #Remdesivir for Hospitalized Adults with #Covid-19
Clinical Outcomes in Patients With Heart #Failure Hospitalized With #COVID-19
The purpose of this study was to evaluate in-hospital outcomes among patients with a history of heart failure (HF) hospitalized with coronavirus disease-2019 (COVID-19).. ..Among 1,212,153 patients with history of HF, 132,312 patients were hospitalized from April 1, 2020, to September 30, 2020. A total of 23,843 patients (18.0%) were hospitalized with acute HF, 8,383… Continue reading Clinical Outcomes in Patients With Heart #Failure Hospitalized With #COVID-19
A Neutralizing Monoclonal #Antibody for Hospitalized Patients with Covid-19
LY-CoV555, a neutralizing monoclonal antibody, has been associated with a decrease in viral load and the frequency of hospitalizations or emergency department visits among outpatients with coronavirus disease 2019 (Covid-19). Data are needed on the effect of this antibody in patients who are hospitalized with Covid-19 METHODS In this platform trial of therapeutic agents, we… Continue reading A Neutralizing Monoclonal #Antibody for Hospitalized Patients with Covid-19
Diagnosis-wide analysis of #COVID-19 complications: an exposure-crossover study
Many studies reporting coronavirus disease 2019 (COVID-19) complications have involved case series or small cohorts that could not establish a causal association with COVID-19 or provide risk estimates in different care settings. We sought to study all possible complications of COVID-19 to confirm previously reported complications and to identify potential complications not yet known.. ..Among… Continue reading Diagnosis-wide analysis of #COVID-19 complications: an exposure-crossover study
2 Medical News 